Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Appropriate Antibiotic Use for Acute Otitis Media
Your Article Summary
See Latest ArticlesEstimation of an optimal chemotherapy utilisation rate for head and neck carcinoma: Setting an evidence-based benchmark for the best-quality cancer care
European Journal of Cancer, 06/23/09
Ng W et al. - The optimal proportion of patients who should receive chemotherapy in the head and neck carcinoma population has risen significantly over the past 20 years. This temporal rise does not appear to be reflected in the limited actual utilisation rates that are available for comparison.
Today in Head and Neck...keeping you current
Receive free subspecialty "5-minute updates" via email
Consensus Statement on the Terminology and Classification of Central Neck Dissection for Thyroid Cancer
Thyroid, 11/02/09
Nuclear factor-kappa B pathway and response in a phase II trial of bortezomib and docetaxel in patients with recurrent and/or metastatic head and neck squamous cell carcinoma
Annals of Oncology, 10/30/09
Diagnostic Pediatric Computed Tomographic Scans of the Head: Actual Dosage versus Estimated Risk
Plastic and Reconstructive Surgery, 10/12/09
Article Search
Sponsor